Brexanolone for Postpartum Depression: More Data, But Still Some Questions
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD). SAGE-547, now called brexanolone, is an allosteric modulator of GABA-A receptors. We saw the preliminary results of the Sage Therapeutics Phase 3 Hummingbird Program earlier this year. Now we have the final set of results… Read More »